Safety, Tolerability, PK&PD of AZD4721(MAD)+ Compare to PD of AZD5069
Research type
Research Study
Full title
A Phase I, Single Centre, Single-blind, Randomised, Placebo-controlled, Parallel-group Study in Male or Female Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of oral AZD4721 after once daily administration of Multiple Ascending Doses for 10 days, and to compare the Pharmacodynamics with those of one oral dose level of AZD5069 given twice daily for 3 days
IRAS ID
137989
Contact name
James Ritter
Contact email
Sponsor organisation
AstraZeneca AB
Eudract number
2013-003392-36
ISRCTN Number
N/A
Clinicaltrials.gov Identifier
N/A
REC name
South Central - Berkshire B Research Ethics Committee
REC reference
13/SC/0476
Date of REC Opinion
30 Oct 2013
REC opinion
Further Information Favourable Opinion